New Targets in Allergic Rhinitis Management
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Immunology".
Deadline for manuscript submissions: closed (20 June 2021) | Viewed by 495
Special Issue Editor
Interests: allergic rhinitis; asthma; antihistamines; nasal steroids; complementary medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Allergic rhinitis is still considered a trivial disease, though it affects more than 70 million people in Europe. Self-diagnosis and self-treatment are very common, leading to poor control of the disease. To note, in addition to the well-known clinical picture characterized by sneezing and rhinorrhea, nasal obstruction is responsible for sleep impairment as well as for drowsiness during the day, which can negatively affect driving ability, working capacity, and quality of life.
Although the currently available drugs and treatment are very effective and safe and can achieve a satisfying control in most cases, patients frequently do not receive medical advice or are not adherent to prescriptions. Therefore, the disease is still uncontrolled in many cases. Concomitant asthma and the complex relationships between upper and lower airways also need to be pointed out.
Dr. Gianenrico Senna
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- rhinitis
- asthma
- antihistamines
- allergen immunotherapy
- complementary medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
